2018 International Congress Archives - Page 40 of 177

1:15pm-2:45pm: Patterns of rhythmic single unit activity of the subthalamic nucleus in patients with Parkinson’s disease

E. Belova, A. Nezvinskiy, R. Medvednik, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

Parkinson's Disease: Neuroimaging And Neurophysiology · Hall 3FG

1:15pm-2:45pm: PD associated with GBA and LRRK2 mutations: Genotype-phenotype correlation

V. Livneh, G. Yahalom, L. Greenbaum, S. Israeli-Korn, T. Fay-Karmon, S. Hassin, Z. Gan Or (Ramat Gan, Israel)

Parkinson's Disease: Genetics · Hall 3FG

1:15pm-2:45pm: Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)

C. García-Sánchez, B. Pascual-Sedano, A. Gironell, R. Rodriguez, J. Pagonabarraga-Mora, J. Marin-Lahoz, J. Pérez-Perez, A. Campolongo, C. izquierdo, H. Bejr-Kasen, I. Aracil, S. Martínez -Horta, A. Horta, M. Botí, E. Marin, J. Kulisevsky (Barcelona, Spain)

Parkinson's Disease: Cognition · Hall 3FG

1:15pm-2:45pm: Peripheral Inflammatory Mediators in Parkinson’s Disease – A Potential Biomarker

K. Chatterjee, A. Roy, R. Banerjee, S. Halder, S. Choudhury, P. Basu, S. Shubham, H. Kumar (Kolkata, India)

Parkinson's Disease: Pathophysiology · Hall 3FG

1:15pm-2:45pm: Personality Traits and Sleep Quality in Parkinson’s disease patients

JY. Yun, HJ. Kim, HN. Kim, HL. Kim (Seoul, Republic of Korea)

Parkinson's Disease: Psychiatric Manifestations · Hall 3FG

1:15pm-2:45pm: Pharmacological modulation of lysosomal glucocerebrosidase activity in the Thy1-aSYN mouse model of Parkinson’s disease

K. Belarbi, E. Cuvelier, H. Carrie, M.A. Bonte, W. Sibran, C. Leghay, J. Von Gerichten, V. Nordström, R. Sandhoff, T. Comptdaer, N. Jouy, E. Mutez, A. Destee, C. Pincon, B. Gressier, M.C. Chartier-Harlin (Lille, France)

Parkinson's Disease: Pathophysiology · Hall 3FG

1:15pm-2:45pm: Pilot study of a new tool to optimize dopaminergic treatment in Parkinson’s disease: The OPTIPARK Scale Project

J. Máñez Miró, F. Vivancos-Matellano, P. Martínez-Martín (Mostoles, Spain)

Rating Scales · Hall 3FG

1:15pm-2:45pm: Pimavanserin Combined With Anti-Dementia Medications for Parkinson Disease Psychosis

A. Espay, M. Guskey, N. Larsen, B. Coate, J. Vizcarra, S. Factor, J. Friedman, D. Weintraub, A. Lang (Cincinnati, OH, USA)

Parkinson's Disease: Psychiatric Manifestations · Hall 3FG

1:15pm-2:45pm: Pisa syndrome in Parkinson’s disease: Evidence for bilateral vestibulospinal dysfunction

G. Di Lazzaro, T. Schirinzi, S. Di Girolamo, R. Di Mauro, A. Pisani (Rome, Italy)

Parkinson's Disease: Neuroimaging And Neurophysiology · Hall 3FG

1:15pm-2:45pm: PLA2G6-related juvenile-onset Parkinsonism: clinical features and cognitive profile in a cohort of Chinese patients

C. Chen, Y.M. Sun, F.T. Liu, S.S. Luo, Z.T. Ding, J.J. Wu, J. Wang (Shanghai, China)

Parkinson's Disease: Genetics · Hall 3FG